We are thrilled to announce the commencement of construction of our new Active Pharmaceutical Ingredient (API) manufacturing facility.
HomeCategory
Company News Archives – Macsen Labs
As we conclude another remarkable year at Macsen Labs, we review a period characterized by expansion and new initiatives. This retrospective review covers our organization's key accomplishments in 2023-24.
Our API manufacturing facility “Macsen Drugs”, which is WHO-GMP certified and US-FDA registered, has obtained GMP certification from the TGA Australia.
In continuation to our mission and values, we got an opportunity to be a part of a project of re-developing a government school in Odwadiya, Udaipur, Raj.
The Indian patent office has granted a patent to Macsen Drugs. The patent concerns a novel process for synthesizing the compound "Fluorescein Sodium".
The Indian patent office granted a patent to Mr Achal Agrawal. The patent concerns a novel process for synthesizing the compound “Methylthioninium Chloride” or “Methylene Blue”.
The research and development team of Macsen Labs has invented a novel process of making fluorescein sodium in which the resultant product is almost free of water, is of high purity and has a free-flowing bright orangish colour/ appearance.